Use-results survey for Bilanoa 20 mg tablet

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080223596

Enrollment

2200

Registered

2017-07-21

Start date

2017-07-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis, urticarial, and itching of skin associated with skin diseases (eczema, dermatitis, and pruritus)

Interventions

investigational material(s) Generic name etc : Bilanoa tablet 20mg INN of investigational material : Bilastine Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for I

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: To be administrated patients for suitable efficacy effect.

Exclusion criteria

Exclusion criteria: To be administrated patients with Bilanoa previously.

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026